CLINICA 100 TOP 10: Cardinal Health
This article was originally published in Clinica
Executive Summary
Cardinal Health retains its No 7 spot in this year's Clinica 100 league table. Cardinal Health made one small acquisition in 2014, acquiring AccessClosure, a maker of extravascular closure devices, for $320m. However, this year it pushed the boat out and signed a $1.94bn deal to acquire Johnson & Johnson’s interventional cardiology business Cordis, the one-time leader in coronary stents. The acquisition ties in with Cardinal Health’s strategy to offer high-value but commoditized products in a cost-efficient way.
You may also be interested in...
Could Alcon's CyPass Trouble Be Boon For Glaukos – Or Bust For MIGS?
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roche Dx' EMEA Head To Take Charge After Diggelmann Departs
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Nose For A Good Tech? Philips Adds Nasal Alar Pulse Oximetry To Monitoring Portfolio
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.